Navigation Links
AMPLICOR HIV-1 Monitor Test, v1.5

ProductsAMPLICOR HIV-1 Monitor Test, v1.5
Company Roche Diagnostics
Item AMPLICOR HIV-1 Monitor Test, v1.5
Features 
  • High levels of sensitivity for an accurate measurement of viral suppression in patients on anti-retroviral therapy
  • 100% specificity
  • A domain of linearity from 50 to 750,000 copies/mL1
  • Proven performance in major pharmaceutical studies
  • The only FDA-approved test which can measure HIV-1 RNA down to 50 copies/mL
  • Quantification of HIV-1 Group M subtypes A-G
Description The AMPLICOR HIV-1 MONITOR Test, v1.5, an FDA-approved HIV-1 RNA assay, is utilized for HIV-1 viral load testing, has been used in the regulatory approval for HIV-1 therapies, and is now found in eight out of 10 clinical laboratories worldwide.

The AMPLICOR HIV-1 MONITOR Test, v1.5 is an in vitro nucleic acid amplification test for the quantification of Human Immunodeficiency Virus Type 1 (HIV-1) RNA in human plasma. The test can be used to assess patient prognosis by measuring the baseline HIV-1 RNA level and to monitor the effects of anti-retroviral therapy by measuring changes in plasma HIV-1 RNA levels during the course of anti-retroviral treatment.

The Gold Standard in Viral Load Assessment

The AMPLICOR HIV-1 MONITOR Test was the first commercial FDA-approved test to quantify the amount of HIV-1 RNA. This test has been used for FDA approval of most of the currently approved anti-retroviral drugs. With a limited number of treatment regimens available to HIV-1 patients, the accurate monitoring of viral load levels is essential to establish and monitor the effectiveness of therapeutic regimens, assess the potential of drug resistance and identify treatment failure.

Info Roche DiagnosticsCall Roche Diagnostics to buy products (US and Canada only; other locations use number below) USACanada1-866-415-6694

Customer Service: 1-800-428-5074
Web site: http://www.roche-diagnostics.com

Related medicine products :

1. OraSure HIV-1 Oral Specimen Collection Device
2. OraQuick ADVANCE Rapid HIV-1/2 Antibody Test
3. Reveal Rapid HIV-1 Antibody Test
4. Vironostika HIV-1 Plus O Microelisa System
5. Genetic Systems HIV-1/HIV-2 Peptide EIA
6. ViroSeq HIV-1 Genotyping System
7. Procleix HIV-1/HCV Assay
8. NucliSens HIV-1 QT
9. OraSure HIV-1 Western Blo
10. Genetic Systems HIV-1 Western Blot
11. Cambridge Biotech HIV-1 (Western Blot)
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo...
... determines osmolality at room temperature with the ... get are cryoscopic artifacts due to high ... interfere with freezing point determinations. The superbly ... Vapro osmometer has a much broader range ...
Rapid assay, results in 1 hours,Range 20-800 ng/mL; sensitivity 2.5 ng/mL,Can be used for animal sera; requires extraction protocol and steroid free serum...
... IMMULITE 2000 assays ... with the IMMULITE 2000, ... access immunoassay analyzer. IMMULITE ... through centralization, and a ...
Medicine Products:
(Date:9/30/2014)... Sept. 30, 2014 (HealthDay News) -- There,s no genetic ... type 2 diabetes, a new study says. Some ... D might protect people against type 2 diabetes, raising ... and the blood sugar disease. In this study, ... vitamin D by focusing on genes that control blood ...
(Date:9/30/2014)... TUESDAY, Sept. 30, 2014 (HealthDay News) -- Children conceived either ... the birth of a sibling could be at increased risk ... study,s lead author and an outside expert agree that the ... in autism. "Most importantly, it is important that parents ... even when pregnancies are close together or far apart," said ...
(Date:9/30/2014)... Power plant standards to cut climate-changing carbon emissions ... substantial human health benefits, according to a new ... on the policy options included in the final ... prevent thousands of premature deaths and hospitalizations, and ... every year., In the new study, Health Co-benefits ...
(Date:9/30/2014)... Health Day Reporter TUESDAY, ... who are overweight or obese when diagnosed appear to ... weight-related cancer, new research suggests. , , The finding ... only the potential for developing other cancers associated with ... who reported being overweight or obese prior to diagnosis ...
(Date:9/30/2014)... breast cancer is the leading cause of cancer death ... why so many medical professionals encourage women to get ... only a minority of suspicious mammograms actually leads to ... needless worry for women and their familiesnot to mention ... ultrasounds and biopsies. , Recently, a different type ...
Breaking Medicine News(10 mins):Health News:Gene Study Finds No Proof Vitamin D Guards Against Type 2 Diabetes 2Health News:Spacing Between Sibling Births Tied to Autism Risk in Study 2Health News:Power plant standards could save thousands of US lives every year 2Health News:Power plant standards could save thousands of US lives every year 3Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 2Health News:Obesity Tied to Higher Cancer Risk for Colon Cancer Survivors 3Health News:'Virtual breast' could improve cancer detection 2
... I-Therapeutix, Inc. announced today that Mr. Richard Packard ... Unit, King Edward VII Hospital, Windsor, UK, performed the ... Mark approved I-ZIP(R) Adherent Ocular Bandage. All phacoemulsification ... Packard. Patients received a foldable IOL with wound-assisted ...
... to Benefit the IP - Over $2,200 In ... Donald Verger, award-winning photographer and philanthropist is taking ... it to help raise awareness for the nonprofit ... deeply grateful to Mr. Verger for using his ...
... 3 Zimmer Holdings, Inc. (NYSE: ZMH ; ... earnings conference call will be broadcast live over the Internet ... A news release detailing the quarterly results will be ... call.The live audio webcast can be accessed via Zimmer,s Investor ...
... save brain cells from ravages of neurodegenerative disease , , ... they,ve found a possible way to prevent brain cells ... , The work is still in the preliminary stages, ... work in humans. Still, a Huntington,s disease expert said ...
... ,s award-winning document management suite recommended for ... and human resourcesCLEVELAND, April 3 It,s no secret. ... at the right time allows for better patient care. ... is they don,t yet have the tools to operate ...
... When the need for speed is critical, how can ... sending alerts to help prevent or stop a public ... be notified about disease outbreaks, illness from food borne ... Researchers from the Regenstrief Institute, Inc. in collaboration with ...
Cached Medicine News:Health News:I-Therapeutix Announces First Commercial Use of I-ZIP(R) Adherent Ocular Bandage for Clear Corneal Cataract Incisions 2Health News:Acclaimed New England Photographer Donald Verger Holds 'Faces of Innocence' Charity Event for the Innocence Project 2Health News:Scientists Uncover New Weapon Against Huntington's 2Health News:American Hospital Association Expands OnBase Endorsement to All Hospital Departments 2Health News:American Hospital Association Expands OnBase Endorsement to All Hospital Departments 3Health News:American Hospital Association Expands OnBase Endorsement to All Hospital Departments 4Health News:Getting the word out when the need for speed is critical to public health 2Health News:Getting the word out when the need for speed is critical to public health 3
(Date:9/30/2014)... 30, 2014   Decision Resources Group finds ... anemic chronic kidney disease non-dialysis (CKD-ND) patients are ... medication. In addition, one-year persistency is similar between ... Other key findings from the report entitled ... Erythropoiesis Stimulating Agents in Late Stage Chronic Kidney ...
(Date:9/30/2014)... SAN DIEGO , 30. September ... Logo - http://photos.prnewswire.com/prnh/20130430/LA01948LOGO ... ein Medizintechnikunternehmen, das ein minimal-invasives 3D-Herzkammer-Bildgebungs- ... der Ursachen entwickelt, die zu komplexen ... aufrechterhalten, hat den Abschluss einer zusätzlichen ...
(Date:9/30/2014)... DIEGO , Sept. 30, 2014   ... developing a minimally invasive real-time 3D Cardiac Chamber Imaging ... that cause and / or sustain complex cardiac arrhythmias, ... $26.2M financing to continue developing its imaging/mapping system as ... The financing will allow Acutus Medical to complete work ...
Breaking Medicine Technology:Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 2Persistency is Low for Late-Stage Anemic CKD Non-Dialysis Patients Treated with Erythropoiesis-Stimulating Agents 3Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 2Acutus Medical, Inc. schließt zusätzliche Finanzierungsrunde Serie B über 26,2 Mio. USD ab, um Portfolio-Erweiterung zu finanzieren 3Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 2Acutus Medical, Inc. Completes Additional $26.2M Series B Financing to Fund Portfolio Expansion 3